middle.news
Algorae Pharmaceuticals Boosts Cash to $5.47M and Expands ANZ Commercial Platform
8:14pm on Friday 15th of May, 2026 AEST
•
Healthcare
Read Story
Algorae Pharmaceuticals Boosts Cash to $5.47M and Expands ANZ Commercial Platform
8:14pm on Friday 15th of May, 2026 AEST
Key Points
Cash reserves rise to $5.47 million after $3.98 million capital inflow
Licence & Supply Agreement signed with Cadila for cardiovascular generics
Exclusive deal with Zydus Lifesciences for 10 pharmaceutical products
Second AI-driven preclinical validation program launched at Peter Mac
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Algorae Pharmaceuticals (ASX:1AI)
OPEN ARTICLE